Case Reports in Infectious Diseases
Volume 2019 (2019), Article ID 8314349, 1 page
https://doi.org/10.1155/2019/8314349

Corrigendum

Corrigendum to “In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways”

Erik Skoglund,¹ Henrietta Abodakpi,¹ Rafael Rios,2,3 Lorena Diaz,2,3,4 Elsa De La Cadena,⁵ An Q. Dinh,3,6 Javier Ardila,² William R. Miller,3,6 Jose M. Munita,3,4,7 Cesar A. Arias,2,3,6,8,9 Vincent H. Tam,¹ and Truc T. Tran3,6

¹University of Houston College of Pharmacy, Houston, TX, USA
²Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogotá, Colombia
³Center for Antimicrobial Resistance and Microbial Genomics, UTHealth McGovern Medical School, Houston, TX, USA
⁴Millennium Initiative for Collaborative Research on Bacterial Resistance (MICROB-R), Santiago, Chile
⁵Grupo de Investigación en Resistencia Antimicrobiana y Epidemiología Hospitalaria–RAEH, Universidad El Bosque, Bogotá, Colombia
⁶Division of Infectious Diseases, UTHealth McGovern Medical School, Houston, TX, USA
⁷Genomics and Resistant Microbes Group, Facultad de Medicina Clinica Alemana, Universidad del Desarrollo, Santiago, Chile
⁸Department of Microbiology and Molecular Genetics, UTHealth McGovern Medical School, Houston, TX, USA
⁹Center for Infectious Diseases, University of Texas School of Public Health, Houston, TX, USA

Correspondence should be addressed to Truc T. Tran; truc.t.tran@uth.tmc.edu

Received 4 March 2019; Accepted 12 March 2019; Published 2 September 2019

Copyright © 2019 Erik Skoglund et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways” [1], a grant number was missing. The Acknowledgments section should be updated as follows.

We thank Morouge Alramadhan for technical support. We also thank the Universidad El Bosque for financial support for whole genome sequencing (Grant no. PCI-2017-9447). This work was supported by the National Institutes of Health (Grant nos. K08-AI113317 (TTT) and K24-AI121296 (CAA)), the Millennium Science Initiative of the Ministry of Economy, Development and Tourism, Government of Chile (JMM), and the Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), FONDECYT 1171805, Ministry of Education, Government of Chile (JMM).

References

E. Skoglund, H. Abodakpi, R. Rios et al., “In Vivo resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa arising by ampC- and non-ampC-mediated Pathways,” Case Reports in Infectious Diseases, vol. 2018, Article ID 9095203, 4 pages, 2018.